{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T05:48:39Z","timestamp":1761976119845,"version":"build-2065373602"},"reference-count":32,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Research in Veterinary Science"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1016\/j.rvsc.2013.04.011","type":"journal-article","created":{"date-parts":[[2013,5,10]],"date-time":"2013-05-10T12:15:36Z","timestamp":1368188136000},"page":"310-315","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Protease expression in giant cell tumour of bone: A comparative study on feline and human samples"],"prefix":"10.1016","volume":"95","author":[{"given":"Leonardo","family":"Leonardi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irene","family":"Quattrini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Franco","family":"Roperto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Serena","family":"Benassi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.rvsc.2013.04.011_b0005","doi-asserted-by":"crossref","first-page":"6986","DOI":"10.1038\/sj.onc.1207859","article-title":"Host-derived plasminogen activator inhibitor-1 (PAI-1) concentration is critical for in vivo tumoural angiogenesis and growth","volume":"23","author":"Bajou","year":"2006","journal-title":"Oncogene"},{"key":"10.1016\/j.rvsc.2013.04.011_b0010","first-page":"1035","article-title":"Tissue and serum loss of metalloproteinase inhibitors in high grade soft tissue sarcomas","volume":"18","author":"Benassi","year":"2003","journal-title":"Histology and Histopathology"},{"key":"10.1016\/j.rvsc.2013.04.011_b0015","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.bbamcr.2010.01.003","article-title":"The tissue inhibitors of metalloproteinases (TIMPs): an ancient family with structural and functional diversity","volume":"1803","author":"Brew","year":"2010","journal-title":"Biochimica et Biophysica Acta"},{"year":"1999","series-title":"Bone and Soft Tissue Tumours","author":"Campanacci","key":"10.1016\/j.rvsc.2013.04.011_b0020"},{"key":"10.1016\/j.rvsc.2013.04.011_b0025","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1097\/01.blo.0000141372.54456.80","article-title":"Bisphosphonates may reduce recurrence in giant cell tumour by inducing apoptosis","volume":"1","author":"Chang","year":"2004","journal-title":"Journal of Clinical Orthopedics"},{"key":"10.1016\/j.rvsc.2013.04.011_b0030","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/00003086-199705000-00027","article-title":"Giant-cell tumour of bone prognosis and treatment of pulmonary metastases","volume":"338","author":"Cheng","year":"1997","journal-title":"Journal of Clinical Orthopedics"},{"key":"10.1016\/j.rvsc.2013.04.011_b0035","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s00223-004-0120-2","article-title":"Bisphosphonates induce apoptosis of stromal tumour cells in giant cell tumour of bone","volume":"75","author":"Cheng","year":"2004","journal-title":"Calcified Tissue International"},{"issue":"1","key":"10.1016\/j.rvsc.2013.04.011_b0040","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/pros.20318","article-title":"CXCL12\/CXCR4 signaling activates Akt-1 and MMP-9 expression in prostate cancer cells: the role of bone microenvironment-associated CXCL12","volume":"66","author":"Chinni","year":"2006","journal-title":"Prostate"},{"issue":"1","key":"10.1016\/j.rvsc.2013.04.011_b0045","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.ajpath.2010.11.035","article-title":"Identification of potential biomarkers for giant cell tumour of bone using comparative proteomics analysis","volume":"178","author":"Conti","year":"2011","journal-title":"American Journal of Pathology"},{"key":"10.1016\/j.rvsc.2013.04.011_b0050","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1097\/00003086-198603000-00003","article-title":"A system of staging musculoskeletal neoplasms","volume":"204","author":"Enneking","year":"1986","journal-title":"Clinical Orthopedics"},{"issue":"5","key":"10.1016\/j.rvsc.2013.04.011_b0055","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1439-0442.2005.00720.x","article-title":"Giant cell tumour of bone in a cat with extraskeletal metastases: pathological and immunohistochemical study","volume":"52","author":"Ferreras","year":"2005","journal-title":"Journal of Veterinary Medicine Series A"},{"key":"10.1016\/j.rvsc.2013.04.011_b0060","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/j.lfs.2006.12.037","article-title":"Receptor activator of NF-kB lingand induces the expression of carbonic anhydrase II cathepsin K and metalloproteinase 9 in osteoclast percursor RAW264.7 cells","volume":"80","author":"Fujisaki","year":"2007","journal-title":"Life Science"},{"issue":"3","key":"10.1016\/j.rvsc.2013.04.011_b0065","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1093\/annonc\/mdh091","article-title":"Proteases and interleukin-6 gene analysis in 92 giant cell tumours of bone","volume":"15","author":"Gamberi","year":"2004","journal-title":"Annals Oncology"},{"key":"10.1016\/j.rvsc.2013.04.011_b0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jor.1100160102","article-title":"Prognostic relevance of Cmyc gene expression in giant-cell tumour of bone","volume":"16","author":"Gamberi","year":"1998","journal-title":"Journal of Orthopedic Research"},{"key":"10.1016\/j.rvsc.2013.04.011_b0075","first-page":"351","article-title":"Identification of markers of possible prognostic value in 57 giant cell tumours of bone","volume":"10","author":"Gamberi","year":"2003","journal-title":"Oncology Report"},{"key":"10.1016\/j.rvsc.2013.04.011_b0080","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1158\/1541-7786.MCR-10-0452","article-title":"Suppression of the uPAR-uPA system retards angiogenesis, invasion, and in vivo tumour development in pancreatic cancer cells","volume":"9","author":"Gorantla","year":"2011","journal-title":"Molecular Cancer Research"},{"key":"10.1016\/j.rvsc.2013.04.011_b0085","first-page":"993","article-title":"Giant cell tumour of bone. Its pathologic appearance, grading, supposed variants and treatment","volume":"30","author":"Jaffe","year":"1940","journal-title":"Archives of Pathology"},{"key":"10.1016\/j.rvsc.2013.04.011_b0090","first-page":"1743","article-title":"Association of urokinase-type plasminogen activator and its inhibitor with disease progression and prognosis in ovarian cancer","volume":"7","author":"Konecny","year":"2001","journal-title":"Clinical Cancer Research"},{"key":"10.1016\/j.rvsc.2013.04.011_b0095","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.humpath.2005.07.005","article-title":"Phenotypic and molecular studies of giant cell tumours of bone and soft tissue","volume":"36","author":"Lau","year":"2005","journal-title":"Human Pathology"},{"key":"10.1016\/j.rvsc.2013.04.011_b0100","first-page":"25","article-title":"Plasminogen activator inhibitor-1: the expression, biological functions and effects on tumourigenesis and tumour cell adhesion and migration","volume":"1","author":"Lee","year":"2005","journal-title":"Journal of Cancer Molecules"},{"issue":"1","key":"10.1016\/j.rvsc.2013.04.011_b0105","first-page":"71","article-title":"A comparative study on phenotypical and biomolecular characterization of Giant Cell Tumour of Bone in feline and human species","volume":"3","author":"Leonardi","year":"2012","journal-title":"Journal of Biomedical and Bioengineering"},{"key":"10.1016\/j.rvsc.2013.04.011_b0110","series-title":"62nd Annual Meeting of the American College of Veterinary Pathologists","first-page":"3","article-title":"Comparative expression profiling in human and feline giant cell tumour of bone","author":"Leonardi","year":"2011"},{"key":"10.1016\/j.rvsc.2013.04.011_b0115","doi-asserted-by":"crossref","first-page":"6690","DOI":"10.1158\/1078-0432.CCR-07-5234","article-title":"Extended efficacy and safety of denosumab in breast cancer patients with bone metastases not receiving prior bisphosphonate therapy","volume":"14","author":"Lipton","year":"2008","journal-title":"Clinical Cancer Research"},{"key":"10.1016\/j.rvsc.2013.04.011_b0120","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1093\/jnci\/94.2.116","article-title":"Pooled analysis of prognostic impact of urokinase-type plasminogen activator and its inhibitor PAI1 in 8377 breast cancer patients","volume":"94","author":"Look","year":"2002","journal-title":"Journal of the National Cancer Institute"},{"key":"10.1016\/j.rvsc.2013.04.011_b0125","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.bone.2010.06.007","article-title":"Matrix metalloproteinases as master regulators of vicious cycle in bone metastasis","volume":"48","author":"Lynch","year":"2011","journal-title":"Bone"},{"key":"10.1016\/j.rvsc.2013.04.011_b0130","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1046\/j.1432-0436.2002.700909.x","article-title":"Matrix metalloproteinases in tumour-host cell comunication","volume":"70","author":"Lynch","year":"2002","journal-title":"Differentiation"},{"key":"10.1016\/j.rvsc.2013.04.011_b0140","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/j.1365-2559.2010.03597.x","article-title":"Differential gene expression in classic giant cell tumours of bone: Tenascin C as biological risk factor for local relapses and metastases","volume":"57","author":"Pazzaglia","year":"2010","journal-title":"Histopathology"},{"key":"10.1016\/j.rvsc.2013.04.011_b0145","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1309\/LK1V7R99JL41WVKP","article-title":"Matrix metalloproteinase expression is related to angiogenesis and histologic grade in spindle cell soft tissue neoplasms of extremities","volume":"123","author":"Roebuck","year":"2005","journal-title":"American Journal of Clinical Pathology"},{"key":"10.1016\/j.rvsc.2013.04.011_b0150","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1002\/jso.10210","article-title":"Quantitative expression of protein markers of plasminogen activation system in prognosis of colorectal cancer","volume":"82","author":"Seetoo","year":"2003","journal-title":"Journal of Surgical Oncology"},{"key":"10.1016\/j.rvsc.2013.04.011_b0160","doi-asserted-by":"crossref","first-page":"331","DOI":"10.2214\/ajr.158.2.1729794","article-title":"Benign giant-cell tumour of bone with pulmonary metastases: clinical findings and radiological appearance of metastases of 13 cases","volume":"158","author":"Tubbs","year":"1992","journal-title":"American Journal of Roentgenology"},{"key":"10.1016\/j.rvsc.2013.04.011_b0165","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1007\/s00264-006-0215-7","article-title":"Giant cell tumour of bone: morphological, biological and histogenetical aspects","volume":"30","author":"Werner","year":"2006","journal-title":"International Orthopaedics"},{"key":"10.1016\/j.rvsc.2013.04.011_b0170","first-page":"49","article-title":"RANK\/RANKL\/OPG: new therapeutic targets in bone tumours and associated osteolysis","volume":"1704","author":"Wittrant","year":"2004","journal-title":"Biochem Biophys Acta"}],"container-title":["Research in Veterinary Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0034528813001379?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0034528813001379?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T03:55:44Z","timestamp":1758513344000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0034528813001379"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["S0034528813001379"],"URL":"https:\/\/doi.org\/10.1016\/j.rvsc.2013.04.011","relation":{},"ISSN":["0034-5288"],"issn-type":[{"type":"print","value":"0034-5288"}],"subject":[],"published":{"date-parts":[[2013,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Protease expression in giant cell tumour of bone: A comparative study on feline and human samples","name":"articletitle","label":"Article Title"},{"value":"Research in Veterinary Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rvsc.2013.04.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}